CSL Health Care
Biopharmaceutical Blood Healthcare Immunodeficiency Plasma

$277.38 -0.92 (-0.33%)

High $278.08	Low $276.68	Trades 24,705	Turnover $270,464,856	Volume 970,129
30 June 2023 at 4:22pm

Register to track CSL and receive email alerts.

Market Cap (21-Sep) $84,262,879,232 (6th)	Close (30-Jun) $277.38 0 (0%)	Volume (30-Jun) 970,129	Shortsold (15-Sep) 7,030,928 (1.47%) (201st)
52w High $216.78	52w Low $88.83	P/E 19.49	EPS -7.55
ASX Announcements (7d) -	Twitter Mentions (7d) 0+	AFR Articles (7d) -	News Articles (7d) 8+

Short Interest

ASIC data, 15 Sep 2026

% Shorted

1.47% 0.01

vs 1.46% prior report

Most Shorted Rank

201st

of 703 shorted ASX stocks

Peak Short

3.33%

Jun 2010

Days to Cover

5.1

at 50d avg vol

View full short position history →

	Subject
	CSL Ann: Final Director's Interest Notice
	1 (current) 2 3
	CSL Ann: Notification of cessation of securities - CSL
	CSL Ann: Resignation of Director
	CSL Ann: Application for quotation of securities - CSL
	CSL Ann: Notification of cessation of securities - CSL
	CSL Ann: Appointment of New Non-Executive Director
	CSL Ann: Appendix 2A
	CSL Ann: Update on CSL Agreement with uniQure
	CSL Ann: Presentation at Macquarie Australia Conference 2021
	CSL Ann: Appendix 2A
	CSL Ann: Appendix 3G
	CSL Ann: Update - Dividend/Distribution - CSL
	CSL Ann: Appendix 2A
	CSL Ann: Appendix 3G
	CSL Ann: Change of Director's Interest Notices
	CSL Ann: Appendix 2A
	CSL Ann: Half Year Results Investor Presentation
	CSL Ann: Half Year Results Announcement
	CSL Ann: Dividend/Distribution - CSL
	CSL Ann: Statutory Accounts for the Half Year Ended 31 Dec 2020
	CSL Ann: Notice of Half Year Results Briefing 2021
	CSL Ann: Appendix 2A
	CSL Ann: Final Director's Interest Notice
	CSL Ann: Resignation of Director
	CSL Ann: Change of Director's Interest Notice
	CSL Ann: Update on UQ-CSL v451 COVID-19 Vaccine
	CSL Ann: New Vaccine Manufacturing Facility
	CSL Ann: Appendix 2A
	CSL Ann: CSLs Annual R&D Investor Briefing 2020
	CSL Ann: Notice of Research & Development Investor Briefing
	CSL Ann: Appendix 3G
	CSL Ann: Change of Director's Interest Notice
	CSL Ann: Final Director's Interest Notice

Register to track CSL and receive email alerts.

Similar Companies

Clinuvel Pharmaceuticals

CUV

Immutep

IMM

Imugene

IMU

Mesoblast

MSB

Opthea

OPT

Paradigm Biopharmaceuticals

PAR

PYC Therapeutics

PYC

Race Oncology

RAC

Telix Pharmaceuticals

TLX

End of Day Prices

Date	Close	Volume	Change
21-Sep	$178.30	811,896	+2.71 (1.54%)
18-Sep	$175.59	3,990,057	-1.97 (1.11%)
17-Sep	$177.56	1,954,673	+3.15 (1.81%)
16-Sep	$174.41	1,411,533	+0.15 (0.09%)
15-Sep	$174.26	1,386,460	+2.69 (1.57%)
14-Sep	$171.57	1,009,254	+4.47 (2.68%)
11-Sep	$167.10	806,570	-2.40 (1.42%)
10-Sep	$169.50	1,090,729	-1.71 (1.00%)
09-Sep	$171.21	1,248,921	-1.31 (0.76%)
08-Sep	$172.52	954,216	-0.66 (0.38%)
07-Sep	$173.18	660,567	-1.32 (0.76%)
04-Sep	$174.50	1,062,918	-1.00 (0.57%)
03-Sep	$175.50	1,143,999	+1.65 (0.95%)
02-Sep	$173.85	705,971	+1.54 (0.89%)
01-Sep	$172.31	1,179,472	+0.74 (0.43%)
8 up, 7 down, and 0 flat days